Sunil HINGORANI

Sunil R. Hingorani, M.D., Ph.D.
Raisbeck Endowed Chair for Pancreatic Research
Member, Fred Hutchinson Cancer Research Center
Professor, University of Washington School of Medicine
Director, Center for Accelerated Translation in Pancreas Cancer
UW/SCCA/Fred Hutch
Deputy Director, Solid Tumor Translational Research
Fred Hutch/UW

Sunil R. Hingorani is a medical oncologist and cancer biologist specializing in pancreas cancer. 

He is Raisbeck Endowed Chair for Pancreatic Research and Member with joint appointments in the Clinical Research and Public Health Sciences Divisions at Fred Hutchinson Cancer Research Center, and Professor in the Department of Medicine, Division of Medical Oncology at University of Washington School of Medicine. He received a B.S. in Molecular Biophysics and Biochemistry from Yale College and a Ph.D. in Cellular and Molecular Physiology and an M.D. from Yale University. He completed a fellowship in hematology and oncology at Dana-Farber Cancer Institute in Boston and performed post-doctoral research at MIT.

Dr. Hingorani is the Founding Director of the Pancreas Cancer Specialty Clinic at the Seattle Cancer Care Alliance, a real-time multidisciplinary clinic which serves as the focal point for a comprehensive translational research program in pancreas cancer, the Center for Accelerated Translation in Pancreas Cancer (CATPAC), which he also directs. His laboratory studies the molecular and cellular pathogenesis of pancreas cancer primarily through the use of genetically engineered mouse models. These animal models of distinct genetic subtypes of pancreas cancer form the basis for an integrated, systematic and multidisciplinary program of study.

Top